Gabelli Funds’s Kindred Biosciences, Inc. KIN Stock Holding History

Gabelli Funds’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-848,344	Closed	-$7.78M	–	1486
2021 Q2	$7.78M	Buy	848,344 +715,844	+540%	+$4.16M	0.05%	410
2021 Q1	$659K	Buy	132,500 +32,500	+33%	+$157K	﹤0.01%	980
2020 Q4	$431K	Buy	100,000 +64,000	+178%	+$260K	﹤0.01%	1025
2020 Q3	$154K	Buy	36,000 +16,000	+80%	+$66.9K	﹤0.01%	1053
2020 Q2	$90K	Buy	20,000 +2,424	+14%	+$10.8K	﹤0.01%	1020
2020 Q1	$70K	Buy	17,576 +1,576	+10%	+$13.4K	﹤0.01%	1024
2019 Q4	$136K	Hold	16,000	–	–	﹤0.01%	1045
2019 Q3	$110K	Buy	16,000 +3,000	+23%	+$22K	﹤0.01%	1077
2019 Q2	$108K	Buy	+13,000	New	+$112K	﹤0.01%	1108

Other funds holding KIN

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

Gabelli Funds's KIN Position: Q3 2021 in Review

Gabelli Funds sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 848,344 shares — an estimated $7.78M sold.

Gabelli Funds first reported a position in KIN in Q2 2019 and held it in 9 quarters. The position peaked at $7.78M in Q2 2021. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.

Gabelli Funds reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
Gabelli Funds sold 848,344 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $7.78M.
Gabelli Funds first reported a position in Kindred Biosciences, Inc. in Q2 2019 and held it in 9 quarters.
Gabelli Funds's Kindred Biosciences, Inc. position peaked at $7.78M in Q2 2021.
1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.

Based on Gabelli Funds's 13F filing for Q3 2021, filed 12 Nov 2021.